S&P 500 Futures
(0.27%) 5 145.50 points
Dow Jones Futures
(0.29%) 38 551 points
Nasdaq Futures
(0.39%) 17 915 points
Oil
(-0.73%) $83.24
Gas
(1.87%) $1.959
Gold
(-0.23%) $2 341.80
Silver
(1.15%) $27.57
Platinum
(0.66%) $928.20
USD/EUR
(-0.26%) $0.932
USD/NOK
(-0.26%) $11.00
USD/GBP
(-0.34%) $0.798
USD/RUB
(0.64%) $92.47

实时更新: QuiaPEG Pharmaceuticals [QUIA.ST]

交易所: STO 部门: Healthcare 工业: Biotechnology
最后更新时间26 Apr 2024 @ 23:29

-1.22% SEK 0.0729

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 23:29):

QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, develops biopharmaceutical products for the treatment of metabolic disorders. It develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides...

Stats
今日成交量 1.70M
平均成交量 1.45M
市值 5.43M
EPS SEK-1.220 ( 2022-12-31 )
下一个收益日期 ( SEK0 ) 2024-06-14
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -2.43
ATR14 SEK0.00200 (2.74%)

音量 相关性

長: -0.12 (neutral)
短: -1.00 (very strong negative)
Signal:(52.355) Neutral

QuiaPEG Pharmaceuticals 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

QuiaPEG Pharmaceuticals 相关性 - 货币/商品

The country flag -0.52
( weak negative )
The country flag -0.47
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.43
( neutral )

QuiaPEG Pharmaceuticals 财务报表

Annual 2023
营收: SEK4.37M
毛利润: SEK2.29M (52.42 %)
EPS: SEK-0.0335
FY 2023
营收: SEK4.37M
毛利润: SEK2.29M (52.42 %)
EPS: SEK-0.0335
FY 2022
营收: SEK5.57M
毛利润: SEK8.91M (159.81 %)
EPS: SEK-6.80
FY 2021
营收: SEK0.00
毛利润: SEK311 000 (0.00 %)
EPS: SEK-0.320

Financial Reports:

No articles found.

QuiaPEG Pharmaceuticals

QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, develops biopharmaceutical products for the treatment of metabolic disorders. It develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. The company has strategic collaboration with Cobra Biologics AB for the refinement of biopharmaceutical products. The company was formerly known as Oligovation AB and changed its name to QuiaPEG Pharmaceuticals Holding AB (publ). QuiaPEG Pharmaceuticals Holding AB (publ) was founded in 2012 and is headquartered in Solna, Sweden.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。